Yet as impressive as the company's results were, the devil's in the details, and one of Oracle's most remarkable metrics may ...

Oracle is behind the AI demand curve, but this could spell accelerating growth and significant upside for investors.

Discover how Oracle's earnings report could influence its full-year 2026 guidance and long-term growth strategy. Read more here.

Oracle Corp. (NYSE:ORCL) reports strong Q3 results, with revenue of $17.19B and adjusted EPS of $1.79. Q4 revenue expected to grow 18-20%.

Oracle shares led the tech sector higher Wednesday as investors cheered the cloud giant's better-than-expected earnings and stronger outlook.

Today’s Forbes Daily newsletter also covers social media for AI agents, Trump’s $6.5 Billion fortune, IPO uncertainty for 2026, FDA warns Novo Nordisk and more.

Oracle (ORCL) closed at $141.31 in the latest trading session, marking a -4.57% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 1.04%. Meanwhile, the Dow lost 1 ...

Oracle is making its Health Clinical AI Agent available to NHS trust and private practices. The note-taking software has been piloted at a number of hospital trusts in the UK, including Barts Health ...

LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new ...

Oracle (ORCL) closed at $146.67 in the latest trading session, marking a -5.17% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.51% for the day. At the same ...